Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

Cancer de la prostate : les activateurs de lymphocytes T « masqués », une immunothérapie prometteuse

(French version only)
By Sheena Cruickshank, Professor in Immunology, University of Manchester
Jonathan Worboys, Research Fellow, Lydia Becker Institute of Immunology and Inflammation, University of Manchester
Cancer de la prostate, leucémie, cancer du poumon… un nouveau type d’immunothérapie pourrait améliorer la prise en charge de ces différents types de cancer.La Conversation


Read complete article

© The Conversation -
Subscribe to Tolerance.ca


Follow us on ...
Facebook Twitter